In humans with X-linked lymphoproliferative (XLP) it has been demonstrated that blocking SLAMF4 and SLAMF6 via antibodies restores T cell function against B cell targets that also express SLAMF members [31]. The gene discussed is SLAMF6; the disease is X-linked lymphoproliferative disease.